An observational study evaluating the efficacy and safety of balloon pulmonary angioplasty and selexipag combination therapy in chronic thromboembolic pulmonary hypertension

An observational study evaluating the efficacy and safety of balloon pulmonary angioplasty and selexipag combination therapy in chronic thromboembolic pulmonary hypertension - An observational study evaluating the efficacy and safety of balloon pulmonary angioplasty and selexipag combination therapy in chronic thromboembolic pulmonary hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056178

Enrollment

Registered

2024-12-01

Start date

2024-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic thromboembolic pulmonary hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CTEPH patients treated at the Department of Cardiology, Keio University Hospital from 1 January 2021 to 31 December 2024. Patients aged 18 or older Patients with BPA implementation history Patients receiving selexipag at 6 months after last BPA procedure

Exclusion criteria

Exclusion criteria: Patients who have requested that their information not be used by the patient or his/her family

Design outcomes

Primary

Measure	Time frame
Hemodynamic changes from baseline (time of diagnosis) 6 months after last BPA	—

Countries

Japan

Contacts

Public ContactAtsushi Anzai

Keio University School of Medicine Department of Cardiology

atsushi_anzai@keio.jp03-5363-3373

Outcome results